PHAXIAM Therapeutics S.A. Euronext Paris
Equities
PHXM
FR0011471135
Biotechnology & Medical Research
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
2.97 EUR | +2.59% | +1.02% | -35.43% |
Mar. 11 | PHAXIAM Therapeutics Completes Delisting of ADS From Nasdaq | MT |
Mar. 11 | Phaxiam Therapeutics Delists from Nasdaq Capital Market | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.43% | 19.12M | |
+1.10% | 106B | |
+9.29% | 103B | |
-2.27% | 21.44B | |
-11.89% | 22.11B | |
-26.59% | 20.99B | |
-5.99% | 19.44B | |
-6.58% | 17.6B | |
+5.83% | 13.88B | |
+7.46% | 11.75B |
- Stock
- Equities
- Stock PHAXIAM Therapeutics S.A.
- Stock PHAXIAM Therapeutics S.A. - Euronext Paris
- News PHAXIAM Therapeutics S.A.
- European Equities Move Lower Friday, Set to End Week in Negative Territory